Nobody can guess the future. But the big multibaggers shared traits while they were still small. We measure those traits on ~340 companies every day, with public data and an open method.
| # | Company | DNA | Market value | Sales | Sector |
|---|---|---|---|---|---|
| 1 | INOD Innodata Inc. | 89 Strong | $2.0 B | +53% | Technology |
| 2 | DAVE Dave Inc. | 80 Strong | $4.5 B | +45% | Technology |
| 3 | HIMS Hims & Hers Health, Inc. | 80 Strong | $6.5 B | +49% | Healthcare |
| 4 | KGC Kinross Gold Corporation | 80 Strong | $26.5 B | +33% | Basic Materials |
| 5 | ALHC Alignment Healthcare, Inc. | 79 Strong | $1.7 B | +39% | Healthcare |
| 6 | LMND Lemonade, Inc. | 79 Strong | $3.5 B | +60% | Financial Services |
| 7 | PAAS Pan American Silver Corp. | 79 Strong | $16.6 B | +33% | Basic Materials |
| 8 | KLIC Kulicke and Soffa Industries, Inc. | 78 Strong | $3.9 B | +32% | Technology |
| 9 | CELH Celsius Holdings, Inc. | 78 Strong | $7.2 B | +48% | Consumer Defensive |
| 10 | VIAV Viavi Solutions Inc. | 78 Strong | $7.5 B | +46% | Technology |
Unlocks the moment you pay. Cancel anytime.
Size. The median stock that went ×100 started at about $500 M in value (Mayer). A giant can be excellent and still have no room: that is why the score is capped by size.
Sales growth last quarter and last fiscal year, and whether it is accelerating (O'Neil). Tempered when sales are lumpy.
Gross margin, operating margin and return on equity (Mayer: ≈ 20 % or more).
Free cash flow yield (free cash ÷ value). One of the strongest traits in the study of 464 ×10 stocks (Yartseva).
How much you pay per point of growth (price/sales ÷ growth). Overpaying for the story is the most common trap.
Net cash versus value and liquidity. Without a balance sheet, a bad stretch forces share issuance and dilution.
Public money (government contracts with firm money versus size), megatrends (AI, chips, defense, space, nuclear, rare earths, quantum, biotech) and owners with skin in the game.
No method is always right: the world's best investors are wrong often and win because their hits weigh more. Since October 25, 2026 we save a weekly snapshot of the top 30 with that day's price, and we will show here how they did versus the S&P 500, good or bad.
A 0–100 score measuring how much a company looks today like the big multibaggers (stocks that rose ×10 or ×100) did when they started: size, sales growth, quality, cash, price versus growth, balance sheet and public contracts.
No. It is a map of traits built on public data, not a prediction. It helps decide which companies to study in depth.
Because it is already worth trillions: to grow ×10 again it would have to be worth tens of trillions. The method caps the score by size.
Sources: Christopher Mayer, "100 Baggers" (365 ×100 U.S. stocks, 1962–2014) · Anna Yartseva, "The Alchemy of Multibagger Stocks" (Birmingham City University, CAFE WP 33, 2025; 464 ×10 stocks, 2009–2024) · William O'Neil, CAN SLIM. Company data: Yahoo Finance; contracts: war.gov and USAspending.
Educational and opinion content, not financial advice. A high score does not guarantee the stock will rise.